Ignite Creation Date:
2025-12-25 @ 2:53 AM
Ignite Modification Date:
2026-02-25 @ 5:21 PM
Study NCT ID:
NCT02738333
Status:
COMPLETED
Last Update Posted:
2018-11-16
First Post:
2016-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-12
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-11
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-11
First Submit QC Date:
None
Study First Post Date:
2016-04-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-12
Results First Submit QC Date:
None
Results First Post Date:
2018-03-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2018-11-16
Last Update Post Date Type:
ACTUAL